ResearcherCapital Medical UniversityNo recent work listed
Jie Zhang
Matched on ORCID iD 0000-0001-9210-4154; OpenAlex author ID A5101681601. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 3, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 23
2012: 1 paper · 2013: 2 papers · 2014: none · 2015: 2 papers · 2016: none · 2017: none · 2018: 1 paper
Papers 6
- Brusatol Enhances the Chemotherapy Efficacy of Gemcitabine in Pancreatic Cancer via the Nrf2 Signalling Pathway. Co-author DOI 10.1155/2018/2360427↗
- Catechol-O-methyltransferase, a new target for pancreatic cancer therapy. Co-author DOI 10.1111/cas.12648↗
- S100 calcium-binding protein A6 promotes epithelial-mesenchymal transition through β-catenin in pancreatic cancer cell line. Last author DOI 10.1371/journal.pone.0121319↗
- Therapy of Smac mimetic SM-164 in combination with gemcitabine for pancreatic cancer. First author DOI 10.1016/j.canlet.2012.10.039↗
- Analyzing S100A6 expression in endoscopic ultrasonography-guided fine-needle aspiration specimens: a promising diagnostic method of pancreatic cancer. First author DOI 10.1097/mcg.0b013e3182601752↗
- Increased COMT expression in pancreatic cancer and correlation with clinicopathologic parameters. First author DOI 10.1007/s11427-012-4375-y↗
Closest collaborators
The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Lei You · 3 shared papers, 2012–2015 · strength 0.13
- Paper Catechol-O-methyltransferase, a new target for pancreatic cancer therapy. DOI 10.1111/cas.12648↗
- Paper Therapy of Smac mimetic SM-164 in combination with gemcitabine for pancreatic cancer. DOI 10.1016/j.canlet.2012.10.039↗
- Paper Increased COMT expression in pancreatic cancer and correlation with clinicopathologic parameters. DOI 10.1007/s11427-012-4375-y↗
- Li Zhou · 2 shared papers, 2012–2015 · strength 0.09
- Wenming Wu · 2 shared papers, 2012–2015 · strength 0.09
- Yupei Zhao · 2 shared papers, 2012–2015 · strength 0.09
- Keqing Shi · 1 shared paper, 2018 · strength 0.07
- Bicheng Chen · 1 shared paper, 2018 · strength 0.07
- Dinglai Yu · 1 shared paper, 2018 · strength 0.07
- Yukai Xiang · 1 shared paper, 2018 · strength 0.07
- Mengtao Zhou · 1 shared paper, 2018 · strength 0.07
- Chaohao Huang · 1 shared paper, 2018 · strength 0.07
- Xue Chen · 1 shared paper, 2015 · strength 0.06
- Hongmei Dai · 1 shared paper, 2015 · strength 0.05
- Huanwen Wu · 1 shared paper, 2015 · strength 0.05
- Wenze Wang · 1 shared paper, 2015 · strength 0.05
- Bin Zhou · 1 shared paper, 2013 · strength 0.04
- Ge Chen · 1 shared paper, 2013 · strength 0.04
- Yu-Pei Zhao · 1 shared paper, 2013 · strength 0.04
- Taiping Zhang · 1 shared paper, 2013 · strength 0.04
- Ji Li · 1 shared paper, 2012 · strength 0.04
- Jing Zhang · 1 shared paper, 2013 · strength 0.03
- Yan Liang · 1 shared paper, 2013 · strength 0.03
- Guo Zihao · 1 shared paper, 2013 · strength 0.03
- Hao Jianyu · 1 shared paper, 2013 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.